Netherlands Institute for Health Services Research (NIVEL), Utrecht, the Netherlands.
Fogarty International Center, National Institutes of Health, Bethesda, Maryland, USA.
J Glob Health. 2019 Dec;9(2):020421. doi: 10.7189/jogh.09.020421.
Until recently, the World Health Organization (WHO) estimated the annual mortality burden of influenza to be 250 000 to 500 000 all-cause deaths globally; however, a 2017 study indicated a substantially higher mortality burden, at 290 000-650 000 influenza-associated deaths from respiratory causes alone, and a 2019 study estimated 99 000-200 000 deaths from lower respiratory tract infections directly caused by influenza. Here we revisit global and regional estimates of influenza mortality burden and explore mortality trends over time and geography.
We compiled influenza-associated excess respiratory mortality estimates for 31 countries representing 5 WHO regions during 2002-2011. From these we extrapolated the influenza burden for all 193 countries of the world using a multiple imputation approach. We then used mixed linear regression models to identify factors associated with high seasonal influenza mortality burden, including influenza types and subtypes, health care and socio-demographic development indicators, and baseline mortality levels.
We estimated an average of 389 000 (uncertainty range 294 000-518000) respiratory deaths were associated with influenza globally each year during the study period, corresponding to ~ 2% of all annual respiratory deaths. Of these, 67% were among people 65 years and older. Global burden estimates were robust to the choice of countries included in the extrapolation model. For people <65 years, higher baseline respiratory mortality, lower level of access to health care and seasons dominated by the A(H1N1)pdm09 subtype were associated with higher influenza-associated mortality, while lower level of socio-demographic development and A(H3N2) dominance was associated with higher influenza mortality in adults ≥65 years.
Our global estimate of influenza-associated excess respiratory mortality is consistent with the 2017 estimate, despite a different modelling strategy, and the lower 2019 estimate which only captured deaths directly caused by influenza. Our finding that baseline respiratory mortality and access to health care are associated with influenza-related mortality in persons <65 years suggests that health care improvements in low and middle-income countries might substantially reduce seasonal influenza mortality. Our estimates add to the body of evidence on the variation in influenza burden over time and geography, and begin to address the relationship between influenza-associated mortality, health and development.
直到最近,世界卫生组织(WHO)估计全球每年因流感导致的全因死亡负担为 25 万至 50 万例;然而,2017 年的一项研究表明,流感导致的呼吸道疾病相关死亡负担要高得多,仅与流感相关的呼吸道疾病死亡人数就有 29 万至 65 万例,2019 年的一项研究估计,由流感直接引起的下呼吸道感染死亡人数为 9.9 万至 20 万例。在这里,我们重新审视了全球和区域流感死亡负担的估计,并探讨了随时间和地域的变化的死亡趋势。
我们汇编了 2002 年至 2011 年期间代表世卫组织五个区域的 31 个国家的与流感相关的超额呼吸道死亡估计数。我们使用多项插补方法从这些数据中推算出世界上 193 个国家的流感负担。然后,我们使用混合线性回归模型来确定与季节性流感高死亡率负担相关的因素,包括流感病毒的类型和亚型、卫生保健和社会人口发展指标以及基线死亡率。
我们估计,在研究期间,全球每年平均有 38.9 万人(29.4 万至 51.8 万)与流感相关的呼吸道死亡,占所有年度呼吸道死亡人数的~2%。其中,67%的死亡发生在 65 岁及以上的人群中。全球负担估计值不受纳入外推模型的国家选择的影响。对于 65 岁以下的人群,较高的基线呼吸道死亡率、较低的卫生保健获取水平以及以 A(H1N1)pdm09 亚型为主导的季节与较高的流感相关死亡率相关,而较低的社会人口发展水平和 A(H3N2) 亚型的主导地位与 65 岁及以上成年人的较高流感死亡率相关。
我们对与流感相关的超额呼吸道死亡的全球估计与 2017 年的估计一致,尽管采用了不同的建模策略,但与仅捕捉到流感直接导致的死亡的 2019 年的低估计值不一致。我们发现,65 岁以下人群的基线呼吸道死亡率和卫生保健获取水平与流感相关死亡率相关,这表明中低收入国家的卫生保健改善可能会大大降低季节性流感的死亡率。我们的估计增加了关于流感负担随时间和地域变化的证据,并开始解决与流感相关的死亡率、健康和发展之间的关系。